| 摘要 |
<p>The present invention provides means, such as a method, for determining whether a prognosis for a mammalian subject having a colon cancer is worse than a reference prognosis. The method comprises the steps of: providing a sample earlier obtained from the subject; evaluating the amount of RBM3 protein present in at least part of said sample, and determining a sample value corresponding to said evaluated amount; comparing the sample value obtained with a reference value associated with said reference prognosis; and, if said sample value is lower than said reference value, concluding that the prognosis for said subject is worse than said reference prognosis.</p> |
